Covariates | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Age | 0.991 | (0.951–1.032) | 0.659 | |||
Female | Ref | |||||
Male | 2.152 | (0.974–4.751) | 0.058 | |||
Colon primary | Ref | |||||
Rectal primary | 1.268 | (0.436–3.689) | 0.663 | |||
Classic adenocarcinoma | Ref | |||||
Mucinous adenocarcinoma | 1.037 | (0.415–2.589) | 0.938 | |||
Grade I (histology) | Ref | |||||
Grade II (histology) | 0.845 | (0.331–2.156) | 0.725 | |||
Grade III (histology) | 0.889 | (0.309–2.562) | 0.828 | |||
Presenting stage I–III | Ref | |||||
Presenting stage IV | 1.116 | (0.367–3.395) | 0.846 | |||
Metachronous | Ref | |||||
Synchronous | 1.028 | (0.471–2.245) | 0.945 | |||
Peri-op chemo | 0.5350 | (0.159–1.8) | 0.788 | |||
Intra-op IV chemo | 0.8957 | (0.402–1.997) | 0.697 | |||
PCI (continuous) | 1.134 | (1.074–1.198) | < 0.001 | 1.178 | (1.083–1.281) | 0.0001 |
Operative time (hours) | 1.198 | (1.012–1.417) | 0.0355 | 0.772 | (0.5493–1.086) | 0.1375 |
Blood loss (100 ml) | 1.039 | (1.005–1.076) | 0.0263 | 1.004 | (0.947–1.064) | 0.889 |
No complications | Ref | |||||
Grade I (complication) | 2.0827 | (0.704–6.247) | 0.187 | 2.173 | (0.713–6.624) | 0.172 |
Grade II (complication) | 1.692 | (0.422–6.775) | 0.457 | 3.292 | (0.749–14.48) | 0.114 |
Grade III (complication) | 7.242 | (2.229–24.73) | 0.0012 | 6.324 | (1.383–28.919) | 0.0174 |
Grade IV (complication) | 6.852 | (1.905–52.42) | 0.003 | 5.588 | (1.256–24.865) | 0.0238 |